Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| Yesterday 4:28 PM View:  | Denali Therapeutics Inc. (DNLI) | 15-May-24 | Sale (Planned) | 1,674 | $20.39 | $34,132.90 | (1%) 118.04K to 116.37K | |
| 17-Apr-24 5:14 PM View: | Denali Therapeutics Inc. (DNLI) | 15-Apr-24 | Sale (Planned) | 1,666 | $18.29 | $30,471.10 | (1%) 119.71K to 118.04K | |
| 19-Mar-24 4:27 PM View: | Denali Therapeutics Inc. (DNLI) | 15-Mar-24 | Sale (Planned) | 1,666 | $20.10 | $33,486.60 | (1%) 121.38K to 119.71K | |
| 20-Feb-24 5:38 PM View: | Denali Therapeutics Inc. (DNLI) | 15-Feb-24 | Sale (Planned) | 1,666 | $18.37 | $30,604.40 | (1%) 123.04K to 121.38K | |
| 18-Jan-24 6:26 PM View: | Denali Therapeutics Inc. (DNLI) | 16-Jan-24 | Sale (Planned) | 1,666 | $18.42 | $30,687.70 | (1%) 124.71K to 123.04K | |
| 18-Dec-23 7:30 PM View: | Denali Therapeutics Inc. (DNLI) | 15-Dec-23 | Sale (Planned) | 1,666 | $23.39 | $38,967.70 | (1%) 126.37K to 124.71K | |
| 16-Nov-23 6:14 PM View: | Denali Therapeutics Inc. (DNLI) | 15-Nov-23 | Sale (Planned) | 1,666 | $19.13 | $31,870.60 | (1%) 128.04K to 126.37K | |
| 18-Oct-23 4:44 PM View: | Denali Therapeutics Inc. (DNLI) | 16-Oct-23 | Sale (Planned) | 1,666 | $20.66 | $34,419.60 | (1%) 129.71K to 128.04K | |
| 19-Sep-23 4:45 PM View: | Denali Therapeutics Inc. (DNLI) | 15-Sep-23 | Sale (Planned) | 1,666 | $23.62 | $39,347.60 | (1%) 131.37K to 129.71K | |
| 17-Aug-23 6:42 PM View: | Denali Therapeutics Inc. (DNLI) | 15-Aug-23 | Sale (Planned) | 1,666 | $24.30 | $40,483.80 | (1%) 133.04K to 131.37K | |
| 19-Jul-23 5:09 PM View: | Denali Therapeutics Inc. (DNLI) | 17-Jul-23 | Sale (Planned) | 1,666 | $29.60 | $49,313.60 | (1%) 134.7K to 133.04K | |
| 03-Jul-23 4:15 PM View: | Vir Biotechnology, Inc. (VIR) | 30-Jun-23 | Sale (Planned) | 18,000 | $24.66 | $443,916.00 | (1%) 1.33M to 1.32M | |
| 30-Jun-23 5:21 PM View: | Denali Therapeutics Inc. (DNLI) | 28-Jun-23 | Sale (Planned) | 1,666 | $29.84 | $49,709.30 | (1%) 136.37K to 134.7K | |
| 15-Jun-23 5:02 PM View: | Allogene Therapeutics, Inc. (ALLO) | 13-Jun-23 | Grant | 59,649 | -- | -- | 144% 41.45K to 101.1K | |
| 05-Jun-23 5:59 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Jun-23 | Grant | 4,216 | -- | -- | 3% 132.15K to 136.37K | |
| 24-May-23 2:37 PM View: | Vir Biotechnology, Inc. (VIR) | 22-May-23 | Grant | 6,027 | -- | -- | < 1% 1.33M to 1.33M | |
| 09-Mar-23 2:36 PM View: | Vir Biotechnology, Inc. (VIR) | 08-Mar-23 | Sale (Planned) | 17,935 | $22.58 | $405,062.00 | (1%) 1.35M to 1.33M | |
| 09-Feb-23 11:27 AM View: | Vir Biotechnology, Inc. (VIR) | 08-Feb-23 | Sale (Planned) | 17,915 | $28.38 | $508,343.00 | (1%) 1.36M to 1.35M | |
| 11-Jan-23 11:40 AM View: | Vir Biotechnology, Inc. (VIR) | 09-Jan-23 | Sale (Planned) | 17,915 | $25.83 | $462,784.00 | (1%) 1.38M to 1.36M | |
| 09-Dec-22 3:43 PM View: | Vir Biotechnology, Inc. (VIR) | 08-Dec-22 | Sale (Planned) | 17,915 | $25.81 | $462,366.00 | (1%) 1.4M to 1.38M | |
| 09-Nov-22 11:09 AM View: | Vir Biotechnology, Inc. (VIR) | 08-Nov-22 | Sale (Planned) | 17,915 | $27.38 | $490,549.00 | (1%) 1.42M to 1.4M | |
| 11-Oct-22 1:12 PM View: | Vir Biotechnology, Inc. (VIR) | 10-Oct-22 | Sale (Planned) | 17,915 | $20.67 | $370,278.00 | (1%) 1.43M to 1.42M | |
| 09-Sep-22 1:47 PM View: | Vir Biotechnology, Inc. (VIR) | 08-Sep-22 | Sale (Planned) | 17,915 | $21.90 | $392,335.00 | (1%) 1.45M to 1.43M | |
| 09-Aug-22 6:26 PM View: | Vir Biotechnology, Inc. (VIR) | 08-Aug-22 | Market Sale (Planned) | 17,915 | $30.29 | $542,685.00 | (1%) 1.47M to 1.45M | (10%) |
| 12-Jul-22 4:46 PM View: | Vir Biotechnology, Inc. (VIR) | 08-Jul-22 | Market Sale (Planned) | 17,915 | $29.06 | $520,694.00 | (1%) 1.49M to 1.47M | (15%) |
| 17-Jun-22 4:58 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Jun-22 | Grant | 22,089 | -- | -- | 114% 19.36K to 41.45K | |
| 09-Jun-22 4:53 PM View: | Vir Biotechnology, Inc. (VIR) | 08-Jun-22 | Sale (Planned) | 17,915 | $25.84 | $462,976.00 | (1%) 1.51M to 1.49M | |
| 06-Jun-22 8:08 PM View: | Denali Therapeutics Inc. (DNLI) | 02-Jun-22 | Grant | 5,986 | -- | -- | 4% 136.16K to 142.15K | |
| 25-May-22 6:07 PM View: | Vir Biotechnology, Inc. (VIR) | 24-May-22 | Sale (Planned) | 3,374 | $23.82 | $80,368.70 | (< 1%) 1.51M to 1.51M | |
| 25-May-22 6:07 PM View: | Vir Biotechnology, Inc. (VIR) | 23-May-22 | Grant | 6,405 | -- | -- | < 1% 1.5M to 1.51M | |
| 10-May-22 5:44 PM View: | Vir Biotechnology, Inc. (VIR) | 09-May-22 | Sale (Planned) | 14,541 | $20.62 | $299,835.00 | (< 1%) 1.52M to 1.5M | |
| 02-May-22 4:05 PM View: | Vir Biotechnology, Inc. (VIR) | 28-Apr-22 | Sale (Planned) | 17,915 | $20.90 | $374,424.00 | (1%) 1.54M to 1.52M | |
| 20-Jan-22 5:01 PM View: | Vir Biotechnology, Inc. (VIR) | 18-Jan-22 | Private Sale (Planned) | 15,173 | $37.39 | $567,385.00 | (< 1%) 1.55M to 1.54M | |
| 21-Dec-21 6:13 PM View: | Vir Biotechnology, Inc. (VIR) | 20-Dec-21 | Market Sale (Planned) | 15,174 | $54.53 | $827,485.00 | (< 1%) 1.57M to 1.55M | 6% |
| 30-Nov-21 4:54 PM View: | Vir Biotechnology, Inc. (VIR) | 26-Nov-21 | Market Sale (Planned) | 15,174 | $36.80 | $558,403.00 | (< 1%) 1.58M to 1.57M | (10%) |
| 12-Nov-21 4:31 PM View: | Denali Therapeutics Inc. (DNLI) | 10-Nov-21 | Market Sale (Planned) | 1,666 | $52.81 | $87,982.90 | (1%) 127.83K to 126.17K | 3% |
| 03-Nov-21 5:30 PM View: | Denali Therapeutics Inc. (DNLI) | 01-Nov-21 | Market Sale (Planned) | 1,666 | $50.05 | $83,383.30 | (1%) 129.5K to 127.83K | (2%) |
| 20-Oct-21 5:03 PM View: | Vir Biotechnology, Inc. (VIR) | 19-Oct-21 | Market Sale (Planned) | 15,174 | $39.56 | $600,314.00 | (< 1%) 1.6M to 1.58M | (2%) |
| 21-Sep-21 10:00 PM View: | Vir Biotechnology, Inc. (VIR) | 17-Sep-21 | Market Sale (Planned) | 15,174 | $52.48 | $796,301.00 | (< 1%) 1.61M to 1.6M | 16% |
| 17-Sep-21 4:04 PM View: | Denali Therapeutics Inc. (DNLI) | 15-Sep-21 | Market Sale (Planned) | 1,666 | $53.40 | $88,969.50 | (1%) 131.16K to 129.5K | < 1% |
| 23-Aug-21 4:35 PM View: | Vir Biotechnology, Inc. (VIR) | 19-Aug-21 | Market Sale (Planned) | 15,174 | $45.05 | $683,611.00 | (< 1%) 1.63M to 1.61M | (3%) |
| 20-Aug-21 5:29 PM View: | Denali Therapeutics Inc. (DNLI) | 18-Aug-21 | Market Sale (Planned) | 1,666 | $51.70 | $86,138.80 | (1%) 132.83K to 131.16K | 6% |
| 03-Aug-21 5:37 PM View: | Allogene Therapeutics, Inc. (ALLO) | 30-Jul-21 | Grant | 19,362 | -- | -- | 100% 0 to 19.36K | |
| 23-Jul-21 5:33 PM View: | Denali Therapeutics Inc. (DNLI) | 21-Jul-21 | Market Sale (Planned) | 1,666 | $65.13 | $108,510.00 | (1%) 134.5K to 132.83K | < 1% |
| 20-Jul-21 8:51 PM View: | Vir Biotechnology, Inc. (VIR) | 19-Jul-21 | Market Sale (Planned) | 15,174 | $37.20 | $564,509.00 | (< 1%) 1.64M to 1.63M | (4%) |
| 24-Jun-21 4:51 PM View: | Denali Therapeutics Inc. (DNLI) | 23-Jun-21 | Market Sale (Planned) | 1,666 | $70.74 | $117,845.00 | (1%) 136.16K to 134.5K | (< 1%) |
| 22-Jun-21 7:57 PM View: | Vir Biotechnology, Inc. (VIR) | 21-Jun-21 | Market Sale (Planned) | 15,174 | $46.17 | $700,515.00 | (< 1%) 1.66M to 1.64M | (6%) |
| 04-Jun-21 6:36 PM View: | Denali Therapeutics Inc. (DNLI) | 02-Jun-21 | Grant | 2,074 | -- | -- | 2% 134.09K to 136.16K | |
| 28-May-21 4:03 PM View: | Denali Therapeutics Inc. (DNLI) | 26-May-21 | Market Sale (Planned) | 1,666 | $65.37 | $108,911.00 | (1%) 135.75K to 134.09K | (< 1%) |
| 25-May-21 4:34 PM View: | Vir Biotechnology, Inc. (VIR) | 21-May-21 | Grant | 3,374 | -- | -- | < 1% 1.65M to 1.66M |